VA's Payment for Leqembi a Positive Move for Biogen.
TL;DR
The Veterans Health Administration will cover Biogen and Eisai's Alzheimer's disease therapy, Leqembi, for the patients it serves, under certain restrictive criteria. However, the goal of full Medicare coverage remains a long way off.
Topics:businesshealthcare#alzheimers-disease#biogen#eisai#healthcare#leqembi#veterans-health-administration
Want the full story? Read the original reporting
Read on Barron's